gajananmnm
5+ Views

Medical Supplies Market - Future Growth, Comprehensive Analysis & Key Players

According to the new market research report Medical Supplies Market by Type (Diagnostic, Dialysis, Wound Care, Disinfectants, PPE, Radiology, Sterilization, Catheters), Application (Urology, Cardiology, Infection Control), End User (Hospitals, Clinics & Physician Offices) – Global Forecast to 2025″, published by MarketsandMarkets™, is projected to reach USD 133.5 billion by 2025 from USD 132.6 billion in 2020.

Browse in-depth TOC on “Medical Supplies Market
126 – Tables
45 – Figures
227 – Pages

The increasing prevalence of chronic diseases across the globe, increasing government and corporate investments in healthcare projects and infrastructure development, rising demand for infection control measures to curb the occurrence of HAIs, and the rising demand for medical devices are driving the growth of the global medical supplies market. Moreover, the rising medical tourism and emerging markets are expected to offer significant growth opportunities to players operating in the market for coming years.

Catheters accounted for the largest share of the medical supplies market, by type, in 2019

By type, segmented into diagnostic supplies, infusion & injectable supplies, intubation & ventilation supplies, disinfectants, personal protective equipment, sterilization consumables, wound care consumables, dialysis consumables, radiology consumables, catheters, sleep apnea consumables, and other medical supplies. The intubation & ventilation supplies segment is expected to grow at the highest growth rate during the forecast period. The growth of this segment is driven mainly by the rising prevalence of respiratory diseases such as asthma and COPD across the globe.

The other applications segment accounted for the largest market share in 2019

The applications market is categorized into urology, wound care, radiology, respiratory, infection control, cardiology, IVD, and other applications. The other applications segment held the largest market share in 2019, due to factors such as the increasing number of surgical procedures, rising prevalence of dental diseases, and the increasing focus on adhering to proper waste disposal methods.

Hospitals accounted for the largest share of the medical supplies market, by end user, in 2019

The end-user segment of this market is categorized into hospitals, clinics/physician offices, and other end users. Hospitals form the largest and the fastest-growing end-user segment in the medical supply market. This can be attributed to the increasing investments in healthcare systems and the high prevalence of infectious and chronic diseases.


North America was the largest regional market for medical supplies in 2019

The global medical supplies market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest market share, followed by Europe. The increasing incidence of COVID-19 in the US and the implementation of various supportive initiatives by the Canadian Government are the major factors driving the growth of the market in North America.

The prominent players operating in the global medical supplies market include Medtronic (Ireland), Cardinal Health, Inc. (US), BD (US), Johnson & Johnson (US), B. Braun Melsungen AG (Germany), Boston Scientific Corporation (US), Thermo Fisher Scientific, Inc. (US), Baxter International, Inc. (US), Avanos Medical, Inc. (US), 3M (US), Smith & Nephew (Ireland), ConvaTec Group Plc. (UK), Abbott (US), Cook Medical (US), Merit Medical Systems (US), Stryker (US), Terumo Corporation (Japan), Teleflex Incorporated (US), Fresenius Medical Care AG & Co. KGaA (Germany), and Coloplast Group (Denmark).
Comment
Suggested
Recent
Cards you may also be interested in
How COVID-19 Impacted on Drone Taxi in Semiconductors & Electronics Industry ?
COVID-19 Impact on Drone Taxi in Semiconductors and Electronics Industry The spread of COVID-19 has entirely changed people’s life. COVID-19 originated in the city of Wuhan, China, in 2019 and has been continuously spreading all over the world since then. It has been spread to more than 180 countries. The U.S. tops the list, followed by India, Brazil, U.K., and others. As of 16 August 2021 WHO reported 226.24 million positive cases worldwide of which 4.65 million patient has lost their life to the virus. On a positive note, 204.59 million patients have recovered, and 5.63 billion doses have been administrated globally. The pandemic has put the lockdown, travel ban, and business shutdown in most countries, highly impacting the global economy. Due to the pandemic, major industries faced serious disruption such as a break in the supply chain, shut down offices and manufacturing units, and many more. The impact of the COVID-19 pandemic has been unprecedented on a global level. It has greatly affected the aviation industry. The drone taxi market is still in its formative stages; hence, it relies on a shared flight model to make the economics work. After COVID-19, the drone taxi industry has experienced an impressive growth trajectory. Due to the increase in road traffic, the demand for drone taxis has risen tremendously. STRATEGIC DECISION BY MANUFACTURERS AND GOVERNMENT INITIATIVES AFTER COVID-19 Post-COVID manufacturers are taking many strategic decisions to get back their original business place in the market. The companies are conducting many research and development activities to improve the technology involved in drone taxis. Thus, the companies are bringing more advanced technology to increase their market share and being recognized by the clients. For instance, · In July 2021, according to INDIA TODAY, Airbus announced the launch of its new urban mobility copter. The new copter can carry 2,310 kg, the highest take-off weight of a fully electric VTOL aircraft with a distributed drive system. The electric aircraft is 4-seater which the helicopter division of Airbus manufactures. Thus the company has successfully brought forward a flying taxi for the customers · Tecnalia, a Spanish company as launched its first Spanish uncrewed air taxi. The air taxi can carry up to 150 kilograms and travel in approximately 15 minutes urban distances of up to 15 km at around 90 km/h alternating between 100 and 300 meters. The vehicle consists of an aerodynamic cabin of 1.8 by 2 meters with a door and window and four drones placed in the upper and lower part of the ship. Thus the company has come up with the new air taxi which can provide customers with similar experience to that of a car or a bus By looking into the rising demand for drone taxis, the government is also taking different initiatives to boost the market's growth. For instance, · In December 2020, according to Intelligent Transport, The General Office of the State Council of China issued a circular to develop urban air mobility (UAM). The letter urges the development of policies and standards which will regulate the industry and encourage progress. The State Council’s circular also highlighted the potential application of firefighting UAVs. Thus the government is supporting in innovation and applications of our UAM technologies, specifically for aerial firefighting IMPACT ON DEMAND The technological developments hold a promising future for the drone taxi market whereby cities are expected to adopt next-generation transportation systems using automatic systems. Cities worldwide face transportation challenges due to the increasing road traffic, which causes major problems for mass transportation. Thus due to the increase in road traffic problems, the demand for drone taxis is increasing in the market. Also, the urban air mobility program has raised the demand for drone taxis. Many companies are developing a drone taxi and transportation hub for urban and sub-urban areas to solve this problem. For instance, · In December 2020, according to Simple Flying, Boeing, a leading company to develop electric air taxis, came up with its flying taxi. The company has developed an autonomous, multi-rotor passenger air vehicle (PAV) in the Boeing NeXt urban air mobility program. PAV is an electric vertical takeoff and landing (eVTOL) aircraft designed to lead the next generation of on-demand mobility. Thus the company has brought electric air taxis which is safe and reliable for their customers · In November 2020, German aviation start-up Lilium announced the launch of the first U.S. transportation hub for their flying taxis. The companies’ vision is to roll out a network of air taxis in various cities, with an app to hail the vehicles similarly to Uber. Their electric Lilium Jet is five-seater and speeds up to 300 kilometers per hour or 186 miles per hour. Thus the company will expand the flying taxi market in the U.S. IMPACT ON SUPPLY CHAIN Although the demand for the market has increased tremendously after the corona period, it has hampered the market's supply chain. Many electronic components like microcontrollers, chips, sensors, and others are needed to produce a drone taxi. In the lockdown, these electronic component manufacturing companies were shut, leading to the material shortage. This shortage has hampered the growth of the market. Most of the electronic component manufacturing companies are from the Asia-Pacific region. Still, due to the corona outbreak, these companies were shut down, leading to a shortage of raw materials. Also, the restriction on transportation hampers the growth of the market. CONCLUSION Post-COVID, the demand for aviation transportation has tremendously increased, leading to the growth of the market. An increase in the population has led to an increase in traffic on roads, so the demand for drone taxis is increasing to save time on road traffic. The programs live urban air mobility has also raised the demand for drone taxis. Also due to the advancement in technology the customers can have safe and reliable travel in less time than the road transport has risen its demand in the market. · Also, Uber announced their aerial ridesharing service for consumers. They said that initially, uberAIR would cost $5.73 per passenger mile, which will get the cost down to $1.86 per passenger mile before ideally getting to $0.44 per passenger mile. Thus at some point, it will be cheaper to use uberAIR Thus we can observe that the demand for drone taxis is increasing, and manufacturing companies and governments are making different decisions to expand the market.
How COVID-19 Impacted on Automated Cell Cultures in Healthcare Industry ?
COVID-19 Impact on Automated Cell Cultures in Healthcare Industry The economy and businesses across the world have been influenced greatly because of the COVID-19 pandemic. The COVID-19 has spread globally in unprecedented ways due to its high infectious and contagious nature and lack of vaccine. The World Health Organization (WHO) declared COVID-19 as a pandemic due to its increased spread across the globe. According to the situation report of 7th June 2021 by WHO, 174 million corona cases had been reported globally and 3.7 million patients died due to the coronavirus. On a slightly positive note, a total of 157 million people have recovered, and 1.9 million vaccine doses have been administered. Cell culture refers to removing cells from an animal or plant and their subsequent growth in a favorable artificial environment. Automated cell culture systems are instruments that mechanically carry out the steps involved in growing and maintaining a cell culture useful in any lab that works with cell biology, cell signaling, protein expression, or drug discovery. An automated cell culture system helps to grow cell cultures while saving labor time and reducing errors. Increasing demand for cell culture technology in vaccine production and wide acceptance of cell culture techniques in various applications accelerate the market growth. However, the high cost of automated cell culture systems and lack of skilled and certified professionals are expected to obstruct the market growth. COVID-19 pandemic created problems for many drug, clinical, medical equipment, and device manufacturing companies, including market players that provided automated cell culture products & services. Though, different kind of policies has been adopted by different companies across the globe for carrying forward the manufacturing processes. PRICE IMPACT COVID-19 claimed a considerable number of lives worldwide, which is a concern in countries with high patient co-payments and an appreciable number of families going into poverty when members become ill. Consequently, there is a need to review prices and availability of pharmaceutical products during the COVID-19 pandemic to provide future direction. The pandemic has impacted on utilization and prices of pertinent medicines and products but moderated by increased scrutiny. Key stakeholder groups can play a role in enhancing evidence-based approaches and reducing inappropriate purchasing in the future. For instance; • The Price of BACTEC FX-40 Automated Blood Culture System manufactured by BD is USD 10,608.08 • The price of Gibco HEPES, a reagent used in cell culture manufactured by Thermo Fisher Scientific, is USD 30.90 Product cost is the major setback for the market as it is expected to decrease the demand due to high costs. As the instruments and consumables related products such as cell counters, reagents, and buffers have high prices, the cost of automated cell cultures can impact the market. IMPACT ON DEMAND Today, most biotechnology products are primarily dependent on the mass culturing of cell lines. Cell cultures have found applications in diverse areas and serve as a model system for numerous research efforts. An increase in funding from the government for cell-based research is significantly triggering the growth of the market. In addition, cell culture techniques are widely used as an alternative to current egg-based strategies for developing cell-based vaccines. Thus, cell culture technology has been widely used in developing U.S. -licensed vaccines such as vaccines against rubella, smallpox, chickenpox, hepatitis, rotavirus, and polio. For instance, • Over the last month and a half, the Centre for Cellular and Molecular Biology has established stable cultures of COVID-19 causing coronavirus. The lab's ability to culture the virus enables CCMB to develop vaccines and test potential drugs to fight COVID-19. As observed, because of the current COVID-19 situation, the demand for automated cell culture services gradually increased due to the wide acceptance of cell culture techniques in various applications and growth in the biotechnology sector. This shows that various initiatives taken by organizations and market players are helping to tackle this COVID-19 situation as products are made available, and the situation is likely to get better in the future. IMPACT ON SUPPLY CHAIN Lockdown policies in different countries have resulted in the closing of product providers, decreasing walk-in customers to prevent the spread of the disease. This led to a significant delay in the supply of the product. Also, during the lockdown period, the market for online delivery of products has seen a rise, which is normal considering the situation. The companies dealing in the automated cell culture worldwide have taken strategic steps to supply products to people across the world properly. The Coronavirus Disease 2019 (COVID-19) pandemic triggered unprecedented increased demand for some clinical devices, as well as significant disruptions to global medical and clinical device manufacturing and supply chain operations. The FDA is monitoring the medical and clinical product supply chain and working closely with manufacturers and other stakeholders to evaluate the risk of disruptions and prevent or reduce their impact on patients, health care providers, and the public's health at large. For instance, · On March 27th 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was signed into law. The CARES Act added Section 506J to the Federal Food, Drug, and Cosmetic Act (FD&C Act). It provided the FDA—for the first time—with new authority intended to help prevent or mitigate negative public health impacts of medical device supply chain disruptions “during, or in advance of, a public health emergency declared by the Secretary under section 319 of the Public Health Service (PHS) Act.” The FDA issued an immediately in effect guidance, Notifying CDRH of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the FD&C Act During the COVID-19 Public Health Emergency: Guidance for Industry and Food and Drug Administration Staff. This guidance is intended to assist manufacturers in providing the FDA timely, informative notifications about changes in the production of certain medical devices that will help the Agency prevent or mitigate shortages of such devices during the COVID-19 public health emergency. · In April 2020, according to Indian Drug Manufacturers Association (IDMA), Vice-Chairman, T Sathish, the pharma sector in the country has been hit by a shortage of workforce, packaging materials, and transport the COVID-19 lockdown. This has led to a shortage of product packaging materials and has made matters worse for the pharmaceutical companies. He urged the government to permit the supporting industry to function to ensure that the supply chain was not disrupted. This shows that even if the COVID-19 situation disrupts the supply chain of products, the initiatives taken by the government and different companies create hope for the proper supply and use of products available. STRATEGIC DECISIONS FOR MANUFACTURERS COVID-19 might have hampered the supply and use of products, but it also allows companies to improve their business by different means. As a pharmaceutical company always does, it tends to find newer and better ways to treat a disease; the same is true with automated cell culture services and products. Always bringing out better solutions in the market will increase their business efficiency. For instance, · In 2020, in the U.S., the companies with direct exposure to COVID-19 outbreak were taking several actions, including transporting available inventory to areas away from quarantine zones and near ports where it can be accessed for shipping, buying ahead to procure inventory and raw material that are in short supply in impacted areas, activating pre-approved raw material substitutions in places where the primary supplier is impacted. However, a secondary supplier is not updating customers about delays and adjusting customer allocations to optimize profits on near-term revenue or to meet contractual terms and shaping demand by offering a discount on the available inventory in cases where supply may be short for late winter-early spring fulfillment optimizing near-term revenue. This signifies that despite this COVID-19 situation, the companies make different strategic decisions that will make their business grow at least back to pre-pandemic levels. CONCLUSION Pandemic has taken a toll on every aspect of life, including the global economy. With the significant downfalls in many sectors, a collaborative effort of government, industry players, and consumers can win the fight against COVID-19. The first wave had already inflicted severe blows to the population and economy. The currently experiencing the second wave and expected the third wave is likely to be more disastrous to the masses and healthcare markets. As this pandemic situation has resulted in many restrictions in different places around the world, the market players dealing in automated cell culture services and products were still able to manage their stock. Different companies were finding out their way to deal with this pandemic situation. The government and companies around the globe are working together and have issued advice for those who are undergoing treatment during these unprecedented times during COVID-19 lockdown around the world. The supply chain was destroyed, but several steps were taken by the government and companies, which will help them get their needed output for the products. By increasing the material price, the companies can maintain their overall revenue. Thus, different companies dealing in automated cell culture services and products are finding out their ways to deal with this pandemic situation.
How COVID-19 Impacted on Waste Water Treatment in Chemicals & Materials Industry ?
COVID-19 Impact on Waste Water Treatment in Chemicals and Materials Industry Wastewater treatment involves numerous biological, and chemical process where wastewater that contains contaminants are purified after the removal of the pollutants and the effluent obtained after the purification is cycled back to nature. Although treatment of wastewater normally takes place in a wastewater treatment plant or sewage treatment plant, the capacity, as well as technical capability of the facility varies according to the origin of the wastewater. For instance, wastewater that originates from industries is treated in industrial wastewater treatment plants that are employed with advanced chemical, biological and mechanical pieces of equipment and technologies. Some of the most common classifications of wastewater treatment plants include phase separation, biological and chemical separation, polishing, among others. Since the demand for freshwater is growing exponentially day by day, water treatment or recycling has become a necessity, particularly since urbanization is gaining a stronger pace in emerging economies. As water is an important commodity for human survival and demand for the respective product is expanding. Recycling contaminated water has become of paramount importance. As a result, the global wastewater treatment market is gaining popularity and widespread acceptance across various nooks and crannies of the globe. COVID-19 IMPACT ON GLOBAL WASTEWATER TREATMENT MARKET Even though the COVID-19 pandemic disrupted many a market across the globe and inflicted the global economy with one of the toughest crises after World War II, certain markets benefited from the pandemic from moderate to an extensive scale. The global wastewater treatment market is one such market that gained an additional market push due to the pandemic. Since SARS-CoV-2 viruses are capable of being transferred through water, large-scale treatment of water across cities, municipalities have become extremely important to curtail the spread of the virus. Similarly, the need for proper and advanced wastewater treatment in hospitals has become a major priority for governments as well authorities to contain the secondary spread of the virus. As a result, decentralized wastewater treatment plants with multiple disinfection barriers in quarantine centers, isolation wards, among others are gaining popularity across the post-COVID-19 world. In short, due to the growing demand for clean water for various industrial and human indispensabilities, the overall demand for water treatment has been growing exponentially over the years. Further, the spread of COVID-19 boosted the necessity for proper wastewater treatment in varied segments as the SARS-CoV-2 virus is capable of transferring through water sources. However, due to various restrictions in economic developments and investments such as supply disruptions, and emergency measures implemented by the government, the scale of development in the global wastewater treatment market is lackadaisical. AFTERMATH OF COVID-19 AND GOVERNMENT INITIATIVE TO BOOST THE MARKET To minimize the damage caused by the pandemic COVID-19 across the globe, various governments are implementing various measures. However, several such initiatives are boosting the demand as well as sales of the global wastewater treatment market. For instance, · After a considerable scientific exploration into the pandemic and the SARS-CoV-2 virus responsible for the pandemic, the presence of SARS-CoV-2 in sewage treatment plants was confirmed. As a result, the executive secretary of Basel, Rotterdam and Stockholm Convention (BRS) argued for the importance of wastewater management, particularly from the medical, household, among others, and named it as an essential public service to ensure minimal impacts on human and environment in the battle with COVID-19. Such governmental safety measures could spread awareness regarding wastewater treatment and could boost the pace associated with the growth of the global wastewater treatment market. Nonetheless, the pace of growth is still significantly primitive due to various socio-economic limitations associated with various parts of the world. STRATEGIC DECISIONS FOR MANUFACTURERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE Manufacturers in the global wastewater treatment market experienced several adversities due to obstructions in the production facilities. Manufacturers have taken many strategic decisions such as collaboration and partnerships for the development of efficient technologies and for increasing production rate to meet the market demand once it returns to normal. Utilizing e-commerce and the establishment of local supply chains are also some of the new strategies used by various manufacturers to counter the effects of COVID-19. Moreover, several industries have enhanced information transparency among each other and are working together to help each other to overcome the financial constraints experienced and to increase cash flow into the business. PRICE IMPACT The price of water treatment equipment and accessories is expected to fluctuate due to an expected disturbance caused by the outbreak of coronavirus disease (COVID-19). Such market fluctuations have prompted manufacturers to find new contract manufacturers and suppliers to shift production operations along with new contracts for the supply of raw materials. Due to an increase in production cost and reduction in profit margins due to the shortage in raw materials, components, and difficulties in the commercialization of products, many a manufacturer is increasing prices of their products. For instance, · In June 2021, Ecolab Inc., a global leader in water, hygiene, and infection prevention solutions and services, has announced that a pricing hike of 9% and 15% will be introduced to the company’s industrial segment products effective immediately or as contracts permit due to an escalation of energy and raw material costs, limited availability of raw materials and rising transportation, packaging, utility and personnel costs IMPACT ON DEMAND COVID-19 has induced a multi-layered crisis comprising domestic price fluctuations, the overall decline of external demand, along the collapse of prices that have an impact on supply and demand for goods. The impact of this could be contemplated across the globe irrespective of the market. The COVID-19 pandemic has affected every aspect and sector as COVID-19 is an emerging, rapidly evolving situation across the world. However, several manufacturers in the global water treatment market have been utilizing this opportunity to launch new products and to address the demand created by the global discovery that the SARS-COV-2 virus is capable of transiting through wastewater. For Instance, · Suez Group introduced monitors the presence of SARS-CoV-2 in wastewater networks, capable of detecting the British variant, among others. This system manufactured by the Suez Group is currently being used in around 100 local communities in Spain, utilized by around 13 million inhabitants. Similarly, the same system is employed in100 local communities in France, with 1.8 million inhabitants. The same water treatment system is also utilized in the UK, the US, and Latin America. In short, it is appropriate to conclude that the pandemic, COVID-19 has boosted the overall demand for wastewater treatment plants and equipment across the globe. Nevertheless, the extent of the respective demand growth is relatively limited. IMPACT ON SUPPLY CHAIN The sudden outbreak of COVID-19 and its subsequent impact on restrictions on trade and movement of goods has resulted in a shutdown of vast portions of the global economy. This has in turn disrupted supply chains of the global wastewater treatment market due to the limited availability of materials and workforce. Further, due to the lockdown scenario, and restrictions in international trade, several manufacturers are also facing difficulties in clearing their old stocks. As a result, it could be conclusive to say that overall of the supply chain of the global wastewater treatment market is affected horrendously by the COVID-19 pandemic. Nevertheless, the governmental measures to unlock economies and global trade in recent months could be considered as a sign of shimmering hope for the global wastewater treatment market. CONCLUSION To recapitulate, although COVID-19 has caused a major disruption to many global economies, the pandemic has slightly boosted the demand in the global wastewater treatment market due to the fact that the SARS-CoV-2 virus, that is responsible for the pandemic could spread through savage water. The governmental regulations and initiatives regarding the urgency to curtail the pandemic also have been helping the respective market to grow. However, due to disruptions in supply chains of final products as well as raw materials, the global wastewater market is unable to tap into the demand and sales growth provided by the COVID-19 pandemic. As a result, a large-scale price increase is witnessed in products associated with the respective market. When combining and considering all these factors, it could be concluded that though, the pandemic COVID-19 has been difficult for the global wastewater market, lackadaisical progress could be witnessed for the respective market in terms of demand and sales. However, the respective market is capable of fully unleashing its potential and make excellent economic growth once the current disruptions in supply chains and manufacturing have been retracted.
Jasa Pengiriman Bandung Batubara, Sumatera Utara (0816267079)
Bingung mencari Jasa Ekspedisi dan Pengiriman Barang yang terjangkau namun aman pengiriman sampai ke alamat tujuan ? Dapatkan kemudahan pengiriman dan tarif terjangkau di Logistik Express Jasa Pengiriman Bandung Batubara, Sumatera Utara Logistik Express Jasa Pengiriman Bandung Batubara, Sumatera Utara merupakan perusahaan yang menyediakan jasa pengiriman barang ke seluruh wilayah Indonesia. Kami menyediakan pengiriman melalui via darat, laut, maupun udara yang tentunya dengan tarif yang terjangkau dan pengiriman yang aman.Adapun beberapa pelayanan yang LOGISTIK EXPRESS yang dapat kami berikan kepada anda : - Melayani Pickup Area Bandung dan Kab. Bandung sekitarnya. - Pengiriman barang sampai ke alamat tujuan. - Jasa Pengiriman ke Seluruh Wilayah Indonesia - Layanan Muatan Cargo Besar Minimal 30Kg, 50kg, dan 100kg Seluruh Indonesia. Bisa Request Packing kiriman Kirim barang dengan Logistik Express Jasa Pengiriman Bandung Batubara, Sumatera Utara tentu murah tentu mudah. Dibantu dengan team operasional yang handal dan customer service profesional LOGISTIK EXPRESS siap mengirimkan barangmu sampai ke alamat tujuan dengan aman. Layanan Customer Service & Order : 0816267079 Cek tarif pengiriman Bandung lainnya : Ekspedisi Bandung batubara Ekspedisi Bandung batui Ekspedisi Bandung batulicin Ekspedisi Bandung batumarta Ekspedisi Bandung baturaja Ekspedisi Bandung batusangkar Ekspedisi Bandung bau bau Ekspedisi Bandung bawen Ekspedisi Bandung bayung lencir Ekspedisi Bandung belinyu Ekspedisi Bandung belitang Ekspedisi Bandung bengkalis
Immunofluorescence Assay Market - Future Analysis, Trends, And Growth
The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R&D spending & healthcare expenditure. Emerging markets are expected to provide growth opportunities for players operating in the immunofluorescence assays market in the coming years. However, quality concerns over antibodies are the major challenge in this market.  COVID-19 has disrupted healthcare services in most countries worldwide; the worst affected are the US, Russia, Spain, Italy, the UK, India, Germany, and Iran. Immunofluorescence assays are used extensively for the detection of viral antigens, including COVID-19. As a result, the pandemic has increased the demand for immunofluorescence assay products across the globe. These are fast and simple methods that allow researchers to visualize the effects and dynamics of viral infections. In the current global scenario, such methods represent a crucial tool in preventing and treating these pathogens.  Diabetes, cancer, infectious diseases, neurological disorders, autoimmune diseases, cardiovascular diseases, lung disorders, severe pancreatitis, and renal failure are major chronic diseases worldwide.  Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255585571 According to the American Institute for Cancer Research, an estimated 18.1 million cancer cases were reported worldwide in 2018; this is projected to increase to 29.5 million by 2040.  In immunofluorescence assays, imaging instruments are used to visualize and locate the fluorescently labeled antibodies in a sample. These imaging instruments are expensive as they are equipped with advanced features and functionalities.  This can primarily be attributed to the diversified healthcare markets in these countries, coupled with the high incidence of infectious and chronic disorders, increasing healthcare expenditure, and the increasing number of R&D initiatives by various organizations. For example, China and India have both registered a high prevalence rate of diabetes.  The demand for complete solutions from a single provider, like closed-system reagents with calibrated measurements of the required quantity of reagents and controls, among CROs, academic institutes, and research institutes is growing, contributing to this segment's high growth rate.
How Impacted COVID-19 on U.S. Shale Gas in Chemical Industry ?
Impact of COVID-19 on U.S. Shale Gas in Chemical Industry INTRODUCTION Shale gas and shale oil are defined as natural gas & oil from shale formations. Shale is a type of sedimentary rock that is made up of very small clay particles and is highly porous in nature. It is formed in deep ocean water, lagoons, wetlands, and swamps where the water is still enough for extremely fine clay and silt particles to settle to the bottom. Since shale is a porous formation, it serves as both a source and a reservoir for unconventional hydrocarbons. The extraction of oil and gas from a shale formation involves mechanical stimulation. One such technique for stimulation is hydraulic fracturing or fracking. In the fracking process, cracks in and below the Earth's surface are opened and widened by injecting water, chemicals, and sand at high pressure. The combination of horizontal drilling and hydraulic fracking has made it possible to access vast quantities of shale gas that were previously uneconomical to generate. Natural gas output from shale deposits has given the United States natural gas industry a new lease on life. The demand for safe access to energy sources is growing globally. Shale oil and gas have played an important role in meeting global energy demand during the energy revolution and are expected to continue to do so for decades as society transitions to lower-carbon energy sources. The rapid growth of shale oil and gas contributes to increased supply stability and lower commodity prices. According to the United States Energy Information Administration (EIA), in the year 2011, the country’s estimated available natural gas resources totaled 2,552 trillion cubic feet (Tcf). Natural gas from shale deposits, which was once considered to be uneconomical, accounted for 827 Tcf of this resource total. In the year 2020, U.S. dry shale gas production was about 26 trillion cubic feet (Tcf), and equal to about 78% of total U.S. dry natural gas production. IMPACT OF COVID-19 ON U.S. SHALE INDUSTRY Shale oil and gas exploration have, in particular, given the US oil and gas industry new dimensions of development. It has also fueled significant investment in associated infrastructure for gathering, storing, and delivering hydrocarbons to both domestic and foreign markets. In less than a decade, the US shale industry turned the global energy landscape upside down and re-established the US as the global energy leader. The onset of a global pandemic and subsequent drop in oil prices, on the other hand, has taken the momentum out of the shale boom. Due to a sudden drop in demand, the shale industry has immediately self-corrected. Many oil and gas players succumbed to the economic shock resulted from the CoVID-19 and filed for bankruptcy. Chesapeake Energy, a shale leader and once second-largest gas producer in the United States, filed for Chapter 11 bankruptcy protection in late June. According to the United States Energy Information Administration (EIA), the crude-oil output from seven major shale formations in the United states fell by around 56,000 barrels per day (BPD) in August 2020 to just under 7.5 million BPD, which would be the lowest level in two years. The shale industry is closely looped in with the oil and gas industry. The recent downfall of the oil and gas industry during the pandemic has had a severe impact on shale output. Post pandemic, the shale industry peaked, but the industry as a whole lost money. Since 2010, the US shale industry has produced USD 300 billion in net negative free cash flows, damaged more than USD 450 billion in invested capital, and seen more than 190 bankruptcies. With the advent of the coronavirus, the future for shale producers has become even bleaker, with a new bankruptcy filing occurring every week or so in the last few months. The pandemic's effects will be felt far beyond the US shale industry. Despite accounting for less than 10% of global oil and gas output, US shale oil extraction activity accounts for 40% of global shale oil extraction activity and accounts for nearly 100% of the growth in US midstream and export-oriented refining and petrochemical sectors over the last decade. STRATEGIC INITIATIVES DURING COVID-19 · Organization of the Petroleum Exporting Countries (OPEC) agreed on a continuation of March production levels for the month of April, with the exception of Russia and Kazakhstan, which will be authorized to increase production by 130,000 and 20,000 barrels per day, respectively, at their most recent meeting · Saudi Arabia has also agreed to extend its one-million-barrel-per-day voluntary cut for the month of April. · Companies such as Chevron, Shell, Schlumberger, and others have taken initiatives to safeguard their workforce in the ongoing pandemic situation. CONCLUSION On Conclusion, the pandemic has placed the shale industry in a delicate spot as major players are forced to cut down the output. The potential energy landscape in the United States and around the world is highly complex, and its drivers are interconnected. In the not-too-distant future, a wave of consolidation in the US shale industry could be triggered by the poor financial position of many firms and the weak economic outlook. The continuous demand for a ban on fracking, coupled with the effect of COVID, has cracked the shale industry severely. Although, the historic evidence indicates that the shale producers operate more economically. In comparison to 2019, producers in the Permian Basin are saving roughly 20% on good costs.
How COVID-19 Impacted Additive Manufacturing Market in Pharmaceutical Industry ?
COVID-19 Impact on Additive Manufacturing in Pharmaceutical Industry The outbreak of Coronavirus has caused many industries to change the way they operate, and manufacturing industry is no exception. Also, the rise in demand of antiviral drugs was observed along with decrease in demand of drugs for other ailments. The European Fine Chemical Group estimated that 80% and upward of chemicals used in the making pharmaceuticals sold in the Europe region originate from China and India. Everyday millions of patients rely on drugs manufactured and supplied by pharmaceutical industries; shortage of any particular medicine may create chaos. Manufacturers served throughout the pandemic and are still operating to prevent such turmoil. IMPACT ON DEMAND The Coronavirus led to the widespread closure of local manufacturing plants and companies and has badly affected the various region of world. Due to extensive lockdown and isolation the economic activity has affected adversely which has impacted the global economic activity. Manufacturers began to diversify sourcing of raw materials along with investment in spreading production in different regional markets instead of concentrated markets such as India and China. Likely to be long term effect is reindustrialization of pharmaceutical production in countries such as the United States and Europe in order to minimize dependency on imported products, this would lead to rise in demand of additives in above mentioned countries. Moreover the increasing cases of COVID-19 have also paved the way for enhanced demand of additives but due to movement restrictions same decrease in sales was recorded. For instance, · In January 2021, BASF SE had no indication of any major effect on the global activities and supply chain of our BASF Nutrition & Health sector comprising of BASF Pharma Solutions, BASF Animal Nutrition, BASF Human Nutrition, BASF Enzymes and BASF Fragrance Ingredients owing to the COVID-19 pandemic. · In 2020, DuPont de Nemours, Inc. recorded decrease in earning of excipients sales, which belonged to Nutrition and Biosciences segment. This thus signifies that increasing prevalence of COVID-19 poses a life threatening effect to various types of patients already suffering from several kinds of disease among the most recent known COVID-19 pandemic. Thus the demand of effective treatment option that is antiviral drug has enhanced the supply for short term. This thus demonstrates that COVID-19 is accelerating the demand of additive market. PRICE IMPACT Throughout year 2020 the COVID-19 pandemic caused economic turmoil globally, the pharmaceutical industry in particular had to adapt quickly to minimize the impact on its operations and supply chain of drugs worldwide. Raw materials and additives rates have increased due to reduced supplies and delayed manufacturing plans, and shut downs in some countries. The price of additives and raw materials has increased during the COVID-19 pandemic due to numerous air travel restrictions and inefficiency to supply products. For instance, · The shortage has begun to affect API and bulk prices in trades, the average increase in India was reported to be about 10-15%, and is estimated to reach 50% in some cases. · WACKER Chemie AG a Germany based company is about to raise its prices for dispersions and solid resins in Europe, Africa and Middle East region stating that this measure has been necessitated by rise in price of raw materials cost in market. · The Edelweiss Securities predicted that COVID-19 pandemic would cause severe supply disruptions in pharma sectors causing earing cuts by 15%. But globally pharma companies are performing well, in short term most companies are expected to bounce back in five years. This thus signifies that due to COVID-19 pandemic the price of additives used in pharmaceutical productions have increased due to Coronavirus outspread. IMPACT ON SUPPLY As COVID-19 spreading began in China the surge of medicines has been enhanced due to increasing patient’s volume which put a pressure over the supply of pharmaceutical additives. Moreover the COVID-19 pandemic has changed the business environment for more organizations across the globe. Around the world many companies are hugely reliant on supplies and production in China. However the market players are adopting several initiatives in order to maintain a continuous supply of additives. For instance, · As per the news of September, 2020 this has been suggested that Sandoz is working closely with the Association for Accessible Medicines in order to enhance the global pharmaceutical supply chain. · In 2020, Ashland which is an essential supplier, their supply chain continued to operate safely receive, process and ship specialty products during COVID-19. · As per November 2020 Merck KGaA a company specialized in additives and chemicals stated that it continued to leverage their business continuity plans including risk mitigation activities, accelerated investments and adjusted production schedules for few high demand products. · According to the news of March 2020, Roquette Frères stated that they are working in order to minimize the COVID-19 impact on its supply chain. · As per February 2020, FDA closely monitored supply chain with the possibility of potential disruptions in supply of critical medical products in the U.S. Manufacturers alerted FDA about recently added drugs in drugs shortage list. · DFE Pharma claims that their continued production and supply during the pandemic was not affected in Netherlands, India, Germany and New Zealand. Apparently due to COVID-19 effects on global transport industry the shipping companies are charging more than usual. This suggests that increasing prevalence of COVID-19 poses threat for maintaining a continuous supply chain of additives while initiative adopted by market players allows them to manage a continuous supply chain. STRATEGIC DECISIONS OF MANUFACTURERS Additive manufacturing companies are taking so many strategic decisions in order to cope up with the current scenario of COVID-19 pandemic. The companies engaged in manufacturing of additive manufacturers are collaborating so as to accelerate the market growth. Companies have already taken several kinds of strategic initiatives in order to cope up with the Coronavirus situation. Strategic initiatives by market players such as Dow, Ashland, Kerry, BASF SE among others in the market will help them to expand their network and supply chain. This in turn will lead to increasing product sales and hence will enhance the overall company’s revenue. For instance, · In May 2020, Dow during the COVID-19 pandemic was working closely with government officials and medical professionals, using guidance to adjust plans as warranted. · In April 2020, the U.K.’s Medicines and Healthcare Products Regulatory Agency (MHRA) published guidelines on Exceptional GMP flexibilities which allow manufacturers to increase their production capability to minimize risk of product shortage using quality risk management principles and to navigate through international travel restrictions imposed due to COVID-19. · In April 2020, Lubrizol enabled 1 Billion bottles of hand sanitizer globally every month to increase its Carbopol polymer production, which is used as a thickener. The increasing demand and sales of antiviral drugs are fuelling the growth of additive manufacturing in pharmaceutical market. Thus, companies operating in the additive manufacturing in pharmaceutical market are adopting several strategies, including agreements, market expansion to enhance their business. These strategic decisions by the market players helped them to attain a lucrative growth even during the COVID-19 pandemic. CONCLUSION As the pandemic of COVID-19 has resulted in several restrictions throughout the borders but still manufacturers of additive manufacturing in pharmaceutical are able to manage their stocks. The demand and supply of pharmaceutical products increased rapidly due to given medical emergency. Drug shortage caused due to the pandemic is expected to remain limited this way for a short period, also if the pandemic exceeds the shortage of pharmaceutical APIs, chemicals and additives may persist on causing shortage of supply in long run. This would also effect complications in distribution especially due to population movement restrictions across the globe. Various manufacturers are continuously engaging in constantly monitoring the supply chain so as to attain a lucrative growth. The activities and certain changes from COVID-19 would reduce dependency of private pharmaceuticals on alone suppliers such as China.
Protein Engineering : Future, Trends, And Scope
The growth of this market is majorly driven by factors such as the increasing investments in synthetic biology and the growing focus on protein-based drug development by pharmaceutical and biotechnology companies.  The rational protein design segment accounted for the largest share of the market in 2019. The large share of this segment can be attributed to the increasing use and continuous upgrades of bioinformatics platforms and software for protein analysis.  The global market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest share of the global market, closely followed by Europe.  Factors such as the presence of well-established CROs, rising R&D expenditure, and the availability of the latest techniques and instruments for drug discovery research are responsible for the large share of the North American market. However, the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.  Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=898  Monoclonal antibodies accounted for the largest share of the protein engineering market in 2019, majorly due to the high and growing demand for monoclonal antibodies for the treatment of cancer, neurological diseases, and infectious diseases.  The rational protein design segment accounted for the largest share of the market, majorly due to the increasing use and continuous upgrades of bioinformatics platforms and software for protein analysis.  The protein engineering market is segmented into biopharmaceutical companies, contract research organizations, and academic research institutes. Biopharmaceutical companies use protein engineering products extensively in their drug discovery and development activities as these products help in designing models to develop a broad range of protein-based drugs. As a result, biopharmaceutical companies were the largest end-users in this market in 2019.  The major companies operating in the global protein engineering market include Thermo Fisher Scientific (US), Danaher Corporation (US), Agilent Technologies (US), and Bio-Rad Laboratories (US).  Market Research Developments: In 2019, Creative Biolabs (US) launched the cd25 monoclonal antibody. In 2019, Waters Corporation (US) launched Vanguard FIT Cartridge Technology. In 2019, Agilent Technologies (US) acquired BioTek Instruments (US), which helped the company to expand its expertise in cell analysis and establish its position in the immuno-oncology and immunotherapy markets. In 2019, Merck KGaA signed a license agreement with Amunix Pharmaceuticals, Inc. (US). Under this agreement, Amunix will gain the rights to develop therapeutics using the protease-triggered immune activator (ProTIA) technology platform.
Without Conviction Animal-Cruelty Case To End: Animal Treatment
The growth of the animal treatment market can be attributed to increasing government initiatives, which ensure maximum preventive healthcare for animals. A majority of the developed economies have norms that impel owners to have pet insurance.  By animal type, the horse's segment is expected to register the highest growth rate during the forecast period. Based on animal type, the animal treatment market is segmented into dogs, cats, horses, cattle, pigs, and poultry. The percentage of medical treatment received by horses is predicted to grow by 2024. In several countries, racehorses are considered to be of economic importance. Therefore, it becomes imperative for caretakers to provide maximum preventive as well as long-term veterinary care to equine species, as negligence pertaining to equine species may have an economic impact. On average, over 70-75% of the horses receive maximum preventive healthcare.  By treatment type, the veterinary care segment is expected to register the highest growth rate in the forecast period. Based on treatment type, the animal treatment market is segmented into no medicalization, basic medicalization, and veterinary care. Over the years, the demand for veterinary care services has increased. Veterinary clinics and hospitals in developed as well as developing countries are well-equipped with the necessary equipment for diagnosis and treatment. For instance, Banfield Hospital in the US is one of the most sophisticated hospitals that provides diagnostic tests for animals. North America is the largest market for animal treatment North America is the largest market in terms of the consumption of veterinary products. People are well versed with animal healthcare regulations, and hence high-quality care is provided to animals in this region.  Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180479252  However, the animal treatment market has become saturated in the US, as the number of veterinary visits has stabilized. On the contrary, the animal treatment rate in European countries has increased. The increasing standard of living and the growing number of veterinarians providing exceptional medical services to animals are the major factors driving the European animal treatment market. Prominent players in the animal treatment market are Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), Abaxis (US), Virbac SA (France), IDEXX Laboratories, Inc. (US), Neogen Corporation (US), and Heska Corporation (US).